The American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists’ Committees on Pain Medicine and Standards and Practice Parameter have determined a consensus guideline for the use of intravenous Ketamine infusion for acute pain management. Their studies show evidence to support the use of Ketamine for chronic pain varying by condition and dosage. This evidence is from small, uncontrolled studies, with few adverse effects, concluding that higher dosages and frequent use of Ketamine is associated with greater risks. More research involving larger studies with a wider range of conditions, are necessary to create more specific guidelines for patient selection, dose ranges, and long-term effects of intravenous Ketamine as repeated treatments.
Read the abstract here.
Download the full “Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management….” here.